The iPSC Awakens ANGPTL3 in Tangier Disease

被引：3
|
作者：
Lee, Man K. S. [1 ]
Murphy, Andrew J. [1 ]
机构：
[1] Baker Heart & Diabet Inst, Haematopoiesis & Leukocyte Biol, Melbourne, Vic, Australia
来源：
EBIOMEDICINE | 2017年 / 18卷
关键词：
SECRETION; MICE;
D O I：
10.1016/j.ebiom.2017.04.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [41] Is ANGPTL3 the next PCSK9?
    Kiran Musunuru
    Sekar Kathiresan
    Nature Reviews Endocrinology, 2017, 13 (9) : 503 - 504
  • [42] ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
    Farzahna Mohamed
    Brett S. Mansfield
    Frederick J. Raal
    Current Atherosclerosis Reports, 2022, 24 : 959 - 967
  • [43] Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease
    Aghasizadeh, Malihe
    Ghanei, Mahmoud
    Ghoflchi, Sahar
    Asadian-sohan, Parisa
    Haghani, Mohammad
    Kazemi, Tooba
    Esmaily, Habibollah
    Avan, Amir
    Ferns, Gordon A.
    Miri-Moghaddam, Ebrahim
    Ghayour-Mobarhan, Majid
    BIOCHEMICAL GENETICS, 2023, 62 (4) : 2482 - 2494
  • [44] ANGPTL3 Inhibitors - Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism -
    Geladari, Eleni
    Tsamadia, Panagiota
    Vallianou, Natalia G.
    CIRCULATION JOURNAL, 2019, 83 (02) : 267 - 273
  • [45] Genetic and Pharmacological Inactivation of ANGPTL3 is Associated With Reduced Atherosclerotic Cardiovascular Disease
    Dewey, Frederick E.
    Gusarova, Viktoria
    O'Dushlaine, Colm
    Gottesman, Omri
    Van Hout, Cristopher V.
    Bruse, Shannon
    Leader, Joseph B.
    Murray, Michael F.
    Ritchie, Marylyn D.
    Kirchner, H. Lester
    Ledbetter, David H.
    Habegger, Lukas
    Zhao, An
    Shao, Weiping
    Overton, John
    Reid, Jeffrey
    Stahl, Neil
    Murphy, Andrew
    Banerjee, Poulabi
    Mellis, Scott
    Sasiela, William J.
    Carey, David J.
    van den Hoek, Anita M.
    Princen, Hans M.
    Borecki, Ingrid B.
    Shuldiner, Alan R.
    Yancopoulos, George D.
    Gromada, Jesper
    Baras, Aris
    CIRCULATION, 2016, 134
  • [46] ANGPTL8 Promotes the Ability of ANGPTL3 to Inhibit Lipoprotein Lipase
    Davies, Brandon S. J.
    Chi, Xun
    Britt, Emily C.
    Shows, Hannah W.
    Hjelmaas, Alexander J.
    Shetty, Shwetha K.
    Cushing, Emily M.
    Zhang, Ren
    FASEB JOURNAL, 2017, 31
  • [47] Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
    Graham, Mark J.
    Lee, Richard G.
    Brandt, Teresa A.
    Tai, Li-jung
    Fu, Wuxia
    Peralta, Raechel
    Yu, Rosie
    Hurh, Eunju
    Paz, Erika
    McEvoy, Bradley W.
    Baker, Brenda F.
    Pham, Nguyen C.
    Digenio, Andres
    Hughes, Steven G.
    Geary, Richard S.
    Witztum, Joseph L.
    Crooke, Rosanne M.
    Tsimikas, Sotirios
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03): : 222 - 232
  • [48] Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease
    Zhao, Zhuoyan
    Fu, Ying
    Lian, Huan
    Liu, Yixiang
    Liu, Jingyi
    Sun, Lixian
    Zhang, Ying
    CLINICAL CARDIOLOGY, 2024, 47 (03)
  • [49] A Subcutaneous Platform for RNAi Therapeutics Targeting ANGPTL3
    Querbes, William
    Barros, Scott
    Hutabarat, Renta
    Milstein, Stuart
    Kallanthottathil, Rajeev
    Kuchimanchi, Satya
    Charisse, Klaus
    Myers, Rachel
    Manoharan, Muthiah
    Maier, Martin
    Fitzgerald, Kevin
    CIRCULATION, 2013, 128 (22)
  • [50] Dual Mechanisms by Which ANGPTL3 Regulates Low-Density Lipoprotein Cholesterol Levels: Implications for Therapeutic Target of ANGPTL3
    Xu, Yu-Xin
    CIRCULATION, 2017, 136
12345